The global pharmaceutical industry experienced an 11% drop in new job postings related to precision and personalized medicine in Q2 2023 compared with the previous quarter, according to GlobalData’s Job Analytics. This compares to 0.64% decrease versus Q2 2022. Buy the report here.
Notably, Life, Physical, and Social Science Occupations jobs accounted for a 24% share of the global pharmaceutical industry’s precision and personalized medicine-related total new job postings in Q2 2023, down 25% over the prior quarter.
Life, Physical, and Social Science Occupations drive precision and personalized medicine-related hiring activity
Life, Physical, and Social Science Occupations, with a share of 24%, emerged as the top precision and personalized medicine-related job roles within the pharmaceutical industry in Q2 2023, with new job postings drop by 25% quarter-on-quarter. Management Occupations came in second with a share of 20% in Q2 2023, with new job postings dropping by 27% over the previous quarter.
See Also:
The other prominent precision and personalized medicine roles include Computer and Mathematical Occupations with a 6% share in Q2 2023, Healthcare Practitioners and Technical Occupations with a 6% share of new job postings.
Top five companies in pharmaceutical industry accounted for 53% of hiring activity
The top companies, in terms of number of new job postings tracked by GlobalData, as of Q2 2023 were AbbVie, AstraZeneca, Sarepta Therapeutics, F. Hoffmann-La Roche, and Novartis. Together they accounted for a combined share of 53% of all precision and personalized medicine-related new jobs in the pharmaceutical industry.
AbbVie posted 529 precision and personalized medicine-related new jobs in Q2 2023, AstraZeneca 90 jobs, Sarepta Therapeutics 74 jobs, F. Hoffmann-La Roche 69 jobs, and Novartis 62 jobs, according to GlobalData’s Job Analytics.
Hiring activity was driven by the US with a 75.71% share of total new job postings, Q2 2023
The largest share of precision and personalized medicine-related new job postings in the pharmaceutical industry in Q2 2023 was in the US with 75.71% followed by the UK (2.91%) and Germany (2.40%). The share represented by the US was five percentage points lower than the 81.11% share it accounted for in Q1 2023.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Jobs Analytics uses machine learning to uncover key insights from tracking daily job postings for thousands of companies globally. Proprietary analysis is used to group jobs into key thematic areas and granular sectors across the world’s largest industries. classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
